down-arrowleft-arrowright-arrow

Benjamin Dahl Associate

Ben applies his extensive background in biotechnology to address the complex legal challenges faced by Haug Partners’ life science clients.

LOCATION

New York

+1.212.588.0800

745 Fifth Avenue, 10th Floor,
New York, NY 10151

VIEW IN MAPS

OVERVIEW

Benjamin Dahl is an associate in the New York office of Haug Partners, where he focuses on pharmaceutical patent litigation. During law school, Ben honed his written advocacy skills at the Appellate Division of the U.S. Attorney’s Office for the District of Columbia and contributed to the AIPLA Law Journal. His education and work experience in biotechnology and chemistry allow him to take a comprehensive approach to the interdisciplinary legal issues facing clients in the pharmaceutical industry.

  • Chubb, Laura, and Benjamin Dahl. “Federal Circuit Clarifies Prior Decision on Limiting Claim Preambles.” Haug Partners, 19 Aug. 2020, www.haugpartners.com/article/federal-circuit-clarifies-decision/.
  • Dahl, Benjamin. "If It Walks Like a Duck & Quacks Like a Duck, Then It Is Interchangeable with a Duck: Lessons Pharmaceutical Companies & Biosimilar Developers Can Learn from Patent-Infringement Doctrine." 45 AIPLA Q.J. 723 (2017).
  • B.S. Environmental Chemistry, Beloit College
  • M.S. Biotechnology, Georgetown University
  • J.D., George Washington University Law School
  • USPTO
  • New York
  • NYIPLA
  • AIPLA
  • Biotechnology Litigation
  • Hatch-Waxman Litigation
  • Intellectual Property Litigation
  • Life Sciences Litigation
  • PTAB Post-Issuance Proceedings

+1.212.588.0800
bdahl@haugpartners.com

Related Services

  • Biotechnology Litigation
  • Hatch-Waxman Litigation
  • Intellectual Property Litigation
  • Life Sciences Litigation
  • PTAB Post-Issuance Proceedings

BAR ADMISSIONS

  • USPTO
  • New York

Haug Partners LLP
745 Fifth Avenue, 10th Floor,
New York, NY 10151
+1.212.588.0800
haugpartners.com

Benjamin Dahl

Associate

HIGHLIGHT

Ben applies his extensive background in biotechnology to address the complex legal challenges faced by Haug Partners’ life science clients.

OVERVIEW

Benjamin Dahl is an associate in the New York office of Haug Partners, where he focuses on pharmaceutical patent litigation. During law school, Ben honed his written advocacy skills at the Appellate Division of the U.S. Attorney’s Office for the District of Columbia and contributed to the AIPLA Law Journal. His education and work experience in biotechnology and chemistry allow him to take a comprehensive approach to the interdisciplinary legal issues facing clients in the pharmaceutical industry.

PUBLICATIONS

  • Chubb, Laura, and Benjamin Dahl. “Federal Circuit Clarifies Prior Decision on Limiting Claim Preambles.” Haug Partners, 19 Aug. 2020, www.haugpartners.com/article/federal-circuit-clarifies-decision/.
  • Dahl, Benjamin. "If It Walks Like a Duck & Quacks Like a Duck, Then It Is Interchangeable with a Duck: Lessons Pharmaceutical Companies & Biosimilar Developers Can Learn from Patent-Infringement Doctrine." 45 AIPLA Q.J. 723 (2017).

EDUCATION

  • B.S. Environmental Chemistry, Beloit College
  • M.S. Biotechnology, Georgetown University
  • J.D., George Washington University Law School

BAR ADMISSIONS

  • USPTO
  • New York

MEMBERSHIPS

  • NYIPLA
  • AIPLA